NPCE Stock Analysis: Buy, Sell, or Hold?
NPCE - Neuropace, Inc. Common Stock
$15.37
-0.26 (-1.66%)
▼
5d:
-1.73%
30d:
-5.53%
90d:
+18.23%
BUY
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When NPCE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: NPCE shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: NPCE shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: NPCE is currently trading at $15.37, which is considered oversold relative to its 30-day fair value range of $15.43 to $16.61.
Technical Outlook: Technically, NPCE is in a uptrend. Immediate support is located at $14.88, while resistance sits at $16.43.
Market Sentiment: NPCE has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $20.00 (+30.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NPCE is in a uptrend. Immediate support is located at $14.88, while resistance sits at $16.43.
Market Sentiment: NPCE has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $20.00 (+30.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$15.43 -
$16.61
Company Quality Score
52/100
(HOLD)
Options IV Signal
54th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
60.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 54th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 30.1% below Wall St target ($20.00)
Trading Range Analysis
30-Day Trading Range
$15.43 -
$16.61
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$2.10
(13.7%)
Support & Resistance Levels
Support Level
$14.88
Resistance Level
$16.43
Current Trend
Uptrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-51.70
Wall Street Target
$20.00
(+30.1%)
Revenue Growth (YoY)
-2.0%
Profit Margin
-21.7%
Share & Embed Analysis
Last updated: June 23, 2026 9:01 AM ET
Data refreshes hourly during market hours. Next update: 10:01 AM
Data refreshes hourly during market hours. Next update: 10:01 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NPCE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 52 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 59 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 60 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 63 BUY |
Advanced NPCE Option Strategies
Professional options setups generated by AI based on today's NPCE price and gamma walls.
